Journal of Antimicrobial Chemotherapy (2001) 47, 781-787
© 2001 The British Society for Antimicrobial Chemotherapy
Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors
a Medicines Monitoring Unit (MEMO), Department of Clinical Pharmacology and Therapeutics, Level 7, Ninewells Hospital, Dundee DD1 9SY; b Department of Medical Microbiology, Ninewells Hospital, Dundee DD1 9SY, UK
Trimethoprim resistance is increasingly prevalent in community-acquired urinary infections. The objective of this study was to evaluate the association between exposure to community-prescribed trimethoprim and other risk factors in subjects and subsequent trimethoprim-resistant urinary tract infection. The design was a nested case–control study using a record-linkage database. Study subjects submitted a urine sample to the Ninewells Hospital Laboratory between July 1993 and December 1995. Antibiotic exposure in subjects with trimethoprim-resistant isolates (cases) was compared with antibiotic exposure in subjects with trimethoprim-susceptible isolates (controls). Study subjects were drawn from the catchment area of a large teaching hospital in Tayside, Scotland. There were 13765 males and females aged 1–106 years who submitted their first urine sample for culture during the study period. After adjustment for significant risk factors and confounding variables, logistic regression analysis showed exposure to trimethoprim [odds ratio (OR) 4.35] or any antibiotic other than trimethoprim (OR 1.32) to be predictive of resistance. The growth of Proteus spp. (OR 115.14) and bacterial growth other than Escherichia coli and Proteus spp. (OR 2.83) were also predictor variables. Hospitalization in the previous 6 months was not independently associated with trimethoprim resistance. In conclusion, trimethoprim resistance was independently associated with exposure to trimethoprim and to antibiotics other than trimethoprim. Reduction in trimethoprim prescribing alone may not reduce the prevalence of trimethoprim resistance.
* Corresponding author. Tel: +44-1382-632575; Fax: +44-1382-642637; E-mail: doug{at}memo.dundee.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Colgan, J. R. Johnson, M. Kuskowski, and K. Gupta Risk Factors for Trimethoprim-Sulfamethoxazole Resistance in Patients with Acute Uncomplicated Cystitis Antimicrob. Agents Chemother., March 1, 2008; 52(3): 846 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hillier, Z. Roberts, F. Dunstan, C. Butler, A. Howard, and S. Palmer Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study J. Antimicrob. Chemother., July 1, 2007; 60(1): 92 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Reeves The 2005 Garrod Lecture: The changing access of patients to antibiotics - for better or worse? J. Antimicrob. Chemother., March 1, 2007; 59(3): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uzunovic-Kamberovic Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina J. Antimicrob. Chemother., August 1, 2006; 58(2): 344 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Arslan, O. K. Azap, O. Ergonul, F. Timurkaynak, and on behalf of the Urinary Tract Infection Study Gro Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J. Antimicrob. Chemother., November 1, 2005; 56(5): 914 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Barlow and D Nathwani Is antibiotic resistance a problem? A practical guide for hospital clinicians Postgrad. Med. J., November 1, 2005; 81(961): 680 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Hay, M. Thomas, A. Montgomery, M. Wetherell, A. Lovering, C. McNulty, D. Lewis, B. Carron, E. Henderson, and A. MacGowan The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data J. Antimicrob. Chemother., July 1, 2005; 56(1): 146 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Magee, M. L. Heginbothom, and B. W. Mason Finding a strategy: the case for co-operative research on resistance epidemiology J. Antimicrob. Chemother., May 1, 2005; 55(5): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M Killgore, K. L March, and B J. Guglielmo Risk Factors for Community-Acquired Ciprofloxacin-Resistant Escherichia coli Urinary Tract Infection Ann. Pharmacother., July 1, 2004; 38(7): 1148 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P T Donnan, L Wei, D T Steinke, G Phillips, R Clarke, A Noone, F M Sullivan, T M MacDonald, and P G Davey Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data BMJ, May 29, 2004; 328(7451): 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Carrie, C. J. Metge, D. M. Collins, G. K. M. Harding, and G. G. Zhanel Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women J. Antimicrob. Chemother., March 1, 2004; 53(3): 512 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Efstathiou, A. V. Pefanis, D. I. Tsioulos, I. D. Zacharos, A. G. Tsiakou, A. G. Mitromaras, S. E. Mastorantonakis, S. N. Kanavaki, and T. D. Mountokalakis Acute Pyelonephritis in Adults: Prediction of Mortality and Failure of Treatment Arch Intern Med, May 26, 2003; 163(10): 1206 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Steinke, A. Emslie-Smith, P. Boyle, H. K. Young, G. Macfarlane, and P. Davey A population study of first exposure to community antibacterials in children and the suitability of routine urine samples for study of the acquisition of drug resistance J. Antimicrob. Chemother., December 1, 2002; 50(6): 1085 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. I. F. Batchelor, D. W. M. Crook, T. Jones, and I. C. J. W. Bowler Impact of guidelines for the diagnosis of urinary tract infection on trimethoprim susceptibility of Escherichia coli J. Antimicrob. Chemother., January 1, 2002; 49(1): 223 - 224. [Full Text] [PDF]
|
|